Related references
Note: Only part of the references are listed.Body size in relation to incidence of subtypes of haematological malignancy in the prospective Million Women Study
F. Murphy et al.
BRITISH JOURNAL OF CANCER (2013)
Anthropometric characteristics and risk of lymphoid and myeloid leukemia in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Fatemeh Saberi Hosnijeh et al.
CANCER CAUSES & CONTROL (2013)
Aspirin and cancer risk: a quantitative review to 2011
C. Bosetti et al.
ANNALS OF ONCOLOGY (2012)
Growth Signals, Inflammation, and Vascular Perturbations Mechanistic Links Between Obesity, Metabolic Syndrome, and Cancer
Stephen D. Hursting et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?
Hans Carl Hasselbalch
BLOOD (2012)
Alcohol drinking, tobacco smoking and subtypes of haematological malignancy in the UK Million Women Study
M. E. Kroll et al.
BRITISH JOURNAL OF CANCER (2012)
Lung carcinogenesis by tobacco smoke
Stephen S. Hecht
INTERNATIONAL JOURNAL OF CANCER (2012)
Nonsteroidal Anti-inflammatory Drug and Acetaminophen Use and Risk of Adult Myeloid Leukemia
Julie A. Ross et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Long-Term Use of Acetaminophen, Aspirin, and Other Nonsteroidal Anti-Inflammatory Drugs and Risk of Hematologic Malignancies: Results From the Prospective Vitamins and Lifestyle (VITAL) Study
Roland B. Walter et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Linking the Iowa Women's Health Study Cohort to Medicare Data: Linkage Results and Application to Hip Fracture
Beth Virnig et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
Autoimmunity and the risk of myeloproliferative neoplasms
Sigurdur Y. Kristinsson et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Jakking up Tumor Registry reporting of the myeloproliferative neoplasms
H. Andrew Selinger et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Risks of myeloid malignancies in patients with autoimmune conditions
L. A. Anderson et al.
BRITISH JOURNAL OF CANCER (2009)
Prevalence of polycythemia vera and essential thrombocythemia
Xiaomei Ma et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24 577 first-degree relatives of 11 039 patients with myeloproliferative neoplasms in Sweden
Ola Landgren et al.
BLOOD (2008)
Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders
AV Jones et al.
BLOOD (2005)
Body size and composition and the risk of lymphohematopoietic malignancies
RJ MacInnis et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
C James et al.
NATURE (2005)
Nonsteroidal anti-inflammatory drugs as anticancer agents: Mechanistic, pharmacologic, and clinical issues
MJ Thun et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer
AJ Dannenberg et al.
LANCET ONCOLOGY (2001)
Familial polycythemia vera: results from the Swedish Family-Cancer Database
K Hemminki et al.
LEUKEMIA (2001)
Associations of general and abdominal obesity with multiple health outcomes in older women -: The Iowa women's health study
AR Folsom et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
